Product Images Levofloxacin
View Photos of Packaging, Labels & Appearance
- EPM LABELS - 67296 0998
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg (50 Tablet Bottle) - levofloxacin fig1
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg Blister Carton (10 x 10 Unit-dose) - levofloxacin fig2
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 500 mg (50 Tablet Bottle) - levofloxacin fig3
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 500 mg Blister Carton (10 x 10 Unit-dose) - levofloxacin fig4
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 750 mg (20 Tablet Bottle) - levofloxacin fig5
- PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 750 mg Blister Carton (10 x 10 Unit-dose) - levofloxacin fig6
- Chemical Structure - levofloxacin str
Product Label Images
The following 8 images provide visual information about the product associated with Levofloxacin NDC 67296-0998 by Redpharm Drug, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
EPM LABELS - 67296 0998

This is a description for Levofloxacin 750 mg tablets produced by Aurobindo Pharma Limited. The NDC numbers for the tablets are 67296-0998-1, 67296-0998-5, and 67296-0998-7. The tablets are for prescription use only, and come in packages of 10, 5, and 7 tablets. The usual adult dosage should be found in the package insert. The tablets should be stored at a controlled room temperature of 20-25°C (68-77°F). The manufacturer is Aurobindo Pharma Limited in Mahaboob Nagar, India, and the distributor is Redpharm Drug in Eden Prairie, MN 55344. The lot and expiration date for the tablets are provided on the packaging.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg (50 Tablet Bottle) - levofloxacin fig1

Levofloxacin Tablets USP is a prescription medication that is taken once a day. Each tablet contains 250 mg of Levofioxacin USP. The usual adult dosage is indicated in the package insert. It is manufactured in India and distributed by Aurobindo Pharma USA, Inc. The medication guide should be given to each patient. It must be dispensed in well-closed, child-resistant containers and kept out of reach of children. It should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and in the USP-controlled room. The provided text has a code and disclaimer for printing in the coding area, and the mentioned dotted lines should not be printed.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 250 mg Blister Carton (10 x 10 Unit-dose) - levofloxacin fig2

This appears to be a description of a medication called Levofloxacin Tablets USP, with a recommended dosage for adults. The medication is apparently packaged in a unit-dose pack and must be kept in a child-resistant container out of the reach of children. The packaging contains 10 individually sealed tablets that are to be dispensed for outpatient use by a pharmacist, and an accompanying medication guide should be given to each patient. The medication is distributed by Aurabindo Pharma USA and manufactured in India.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 500 mg Blister Carton (10 x 10 Unit-dose) - levofloxacin fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 750 mg (20 Tablet Bottle) - levofloxacin fig5

Each film-coated tablet contains 750mg of Levofloxacin USP. It is distributed by Aurobindo Pharma USA, Inc. and should be dispensed in a well-closed container. The usual adult dosage should be checked on the package insert. It should be dispensed in child-resistant containers and kept out of reach of children. The accompanying Medication Guide should be dispensed to each patient. There is an over printing zone and coding area on the packaging.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 750 mg Blister Carton (10 x 10 Unit-dose) - levofloxacin fig6

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.